Literature DB >> 11533295

Mechanisms governing the expression of the enzymes of glutamine metabolism--glutaminase and glutamine synthetase.

B I Labow1, W W Souba, S F Abcouwer.   

Abstract

Whether on the scale of a single cell, organ or organism, glutamine homeostasis is to a large extent determined by the activities of glutaminase (GA, EC 3.5.1.2) and glutamine synthetase (GS, EC 6.3.1.2), the two enzymes that are the focus of this report. GA and GS each provide examples of regulation of gene expression at many different levels. In the case of GA, two different genes (hepatic- and kidney-type GA) encode isoforms of this enzyme. The expression of hepatic GA mRNA is increased during starvation, diabetes and high protein diet through a mechanism involving increased gene transcription. In contrast, the expression of kidney GA mRNA is increased post-transcriptionally by a mechanism that increases mRNA stability during acidosis. We found recently that several isoforms of rat and human kidney-type GA are formed by tissue-specific alternative RNA splicing. Although the implications of this post-transcriptional processing mechanism for GA activity are not yet clear, it allows for the expression of different GA isoforms in different tissues and may limit the expression of GA activity in muscle tissues by diverting primary RNA transcripts to a spliceform that produces a nonfunctional translation product. The expression of GS enzyme is also regulated by both transcriptional and post-transcriptional mechanisms. For example, the GS gene is transcriptionally activated by glucocorticoid hormones in a tissue-specific fashion. This hormonal response allows GS mRNA levels to increase in selected organs during catabolic states. However, the ultimate level of GS enzyme expression is further governed by a post-transcriptional mechanism regulating GS protein stability. In a unique form of product feedback, GS protein turnover is increased by glutamine. This mechanism appears to provide a means to index the production of glutamine to its intracellular concentration and, therefore, to its systemic demand. Herein, we also provide experimental evidence that GS protein turnover is dependent upon the activity of the 26S proteosome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533295     DOI: 10.1093/jn/131.9.2467S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  25 in total

1.  Glutamine, insulin and glucocorticoids regulate glutamine synthetase expression in C2C12 myotubes, Hep G2 hepatoma cells and 3T3 L1 adipocytes.

Authors:  Yanxin Wang; Malcolm Watford
Journal:  Biochim Biophys Acta       Date:  2006-11-23

2.  Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia.

Authors:  M A Torres-Vega; R Y Vargas-Jerónimo; A G Montiel-Martínez; R M Muñoz-Fuentes; A Zamorano-Carrillo; A R Pastor; L A Palomares
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

Review 3.  Regulation of astrocyte glutamine synthetase in epilepsy.

Authors:  Tore Eid; Nathan Tu; Tih-Shih W Lee; James C K Lai
Journal:  Neurochem Int       Date:  2013-06-18       Impact factor: 3.921

Review 4.  Inborn error of amino acid synthesis: human glutamine synthetase deficiency.

Authors:  Johannes Häberle; Boris Görg; Annick Toutain; Frank Rutsch; Jean-François Benoist; Antoinette Gelot; Annie-Laure Suc; Hans Georg Koch; Freimut Schliess; Dieter Häussinger
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 5.  Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential.

Authors:  Charles R Roe; Fanny Mochel
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Metabolite profiling identifies pathways associated with metabolic risk in humans.

Authors:  Susan Cheng; Eugene P Rhee; Martin G Larson; Gregory D Lewis; Elizabeth L McCabe; Dongxiao Shen; Melinda J Palma; Lee D Roberts; Andre Dejam; Amanda L Souza; Amy A Deik; Martin Magnusson; Caroline S Fox; Christopher J O'Donnell; Ramachandran S Vasan; Olle Melander; Clary B Clish; Robert E Gerszten; Thomas J Wang
Journal:  Circulation       Date:  2012-04-11       Impact factor: 29.690

7.  Interpretation of plasma amino acids in the follow-up of patients: the impact of compartmentation.

Authors:  Claude Bachmann
Journal:  J Inherit Metab Dis       Date:  2008-01-31       Impact factor: 4.982

8.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).

Authors:  Mary M Robinson; Steven J McBryant; Takashi Tsukamoto; Camilo Rojas; Dana V Ferraris; Sean K Hamilton; Jeffrey C Hansen; Norman P Curthoys
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

9.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans.

Authors:  Benjamin P Lewis; Richard E Green; Steven E Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

10.  Characterisation of G418-induced metabolic load in recombinant CHO and BHK cells: effect on the activity and expression of central metabolic enzymes.

Authors:  C A Yallop; P L Nørby; R Jensen; H Reinbach; I Svendsen
Journal:  Cytotechnology       Date:  2003-07       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.